GE Healthcare Shares Rise on Strong Order Growth in Q2 Earnings
Shares of GE Healthcare (NASDAQ: GEHC) rose approximately 12% following its second-quarter earnings report, which showed better-than-expected results and signs of recovery. Despite a challenging year marked by increased costs from memory chips, oil, freight, and raw materials, the company reported an 11.1% increase in orders with a book-to-bill ratio of 1.15 times and a backlog reaching $23.9 billion. The growth in orders is seen as positive for pricing power amid ongoing cost pressures. CFO James Saccaro noted that recent cost actions are stabilizing, contributing to improved margins expected later this year and into 2027. CEO Peter Arduini highlighted new product launches with embedded AI as a driver of future revenue improvements. The market is responding positively to these developments, signaling confidence in GE Healthcare's ability to overcome past challenges.
Topics: Cost Management Earnings Order Growth